BBIO
BridgeBio Pharma, Inc. Common Stock#81 · 2019HTFCYearly return
+27%
Peak return
+76%
Max drawdown
-47%
ADR (20 days)
+9.0%
Base
24 days / -31.0%
Prior run
+125%
Breakout volume
9.8x
Pivot
$39.64
Catalyst Earnings/Guidance2019-12-268-K Ergebnisbekanntgabe (Item 2.02), BridgeBio Pharma, Inc.SEC EDGAR
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker. Beleg: offizielles 8-K-Filing bei der SEC.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare BBIO with the current market directly.